Medtronic plc
MDT · NYSE
10/24/2025 | 7/25/2025 | 4/30/2025 | 1/24/2025 | |
|---|---|---|---|---|
| Revenue | $8,961,000 | $8,578,000 | $8,927,000 | $8,292,000 |
| % Growth | 4.5% | -3.9% | 7.7% | – |
| Cost of Goods Sold | $3,556,000 | $3,632,000 | $3,147,000 | $2,779,000 |
| Gross Profit | $5,405,000 | $4,946,000 | $5,780,000 | $5,513,000 |
| % Margin | 60.3% | 57.7% | 64.7% | 66.5% |
| R&D Expenses | $754,000 | $726,000 | $684,000 | $675,000 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $2,966,000 | $2,806,000 | $2,720,000 | $2,717,000 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$31,000 | $940,000 | $475,000 |
| Operating Expenses | $3,720,000 | $3,501,000 | $4,344,000 | $3,867,000 |
| Operating Income | $1,685,000 | $1,445,000 | $1,436,000 | $1,646,000 |
| % Margin | 18.8% | 16.8% | 16.1% | 19.9% |
| Other Income/Exp. Net | -$89,000 | -$143,000 | -$175,000 | -$106,000 |
| Pre-Tax Income | $1,596,000 | $1,302,000 | $1,261,000 | $1,540,000 |
| Tax Expense | $215,000 | $255,000 | $199,000 | $237,000 |
| Net Income | $1,374,000 | $1,040,000 | $1,057,000 | $1,294,000 |
| % Margin | 15.3% | 12.1% | 11.8% | 15.6% |
| EPS | 1.07 | 0.81 | 0.82 | 1.01 |
| % Growth | 32.1% | -1.2% | -18.8% | – |
| EPS Diluted | 1.07 | 0.81 | 0.82 | 1.01 |
| Weighted Avg Shares Out | 1,281,800 | 1,281,600 | 1,282,300 | 1,282,400 |
| Weighted Avg Shares Out Dil | 1,287,500 | 1,287,100 | 1,287,700 | 1,286,200 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $33,000 | $0 | $0 |
| Interest Expense | $181,000 | $176,000 | $174,000 | $179,000 |
| Depreciation & Amortization | $589,000 | $748,000 | $840,000 | $684,000 |
| EBITDA | $2,366,000 | $2,225,000 | $2,275,000 | $2,403,000 |
| % Margin | 26.4% | 25.9% | 25.5% | 29% |